European Healthtech startup funding raised during Q3 2016.
In Q3 2016, 71 European Healthtech companies raised a combined €397M across 73 funding rounds, down 45.8% versus Q3 2015. Germany led by capital raised, and Bayern Kapital was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Brillen.de | Growth/Late | Jul 2016 | €45M |
| IOmx Therapeutics | Series A | Sep 2016 | €40M |
| Spineart | Growth/Late | Sep 2016 | €30M |
| Artios | Series A | Sep 2016 |
8 exits · €82M disclosed.
| Creo Medical | IPO | Jul 2016 | €74M |
| Cellink | IPO | Aug 2016 | €8.1M |
| €29M |
| Cambridge Medical Robotics | Series A | Jul 2016 | €18M |
| Aspect Imaging | Growth/Late | Jul 2016 | €18M |
| Nyxoah | Series B | Jul 2016 | €18M |
| Vivasure Medical | Series C | Sep 2016 | €16M |
| Inflazome | Series A | Sep 2016 | €15M |
| Rigontec | Series A | Sep 2016 | €14M |
| NightBalance | Series B | Jul 2016 | €13M |
| Big Health | Series B | Jul 2016 | €11M |
| Lifesum | Series B | Jul 2016 | €9.1M |
| ImmunArray | Series B | Jul 2016 | €9.1M |
| Eyevensys | Series A | Sep 2016 | €9.0M |
